Log In
Print this Print this

DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System

  Manage Alerts
Collapse Summary General Information
Company Elixir Medical Corp.
DescriptionPoly-L Lactide (PLLA)-based polymer coronary scaffold that delivers novolimus
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today